Credit Suisse’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $159K | Sell |
|
|||||
|
2023
Q2 | $347K | Buy |
|
|||||
|
2023
Q1 | $154K | Buy |
|
|||||
|
2022
Q4 | $121K | Buy |
|
|||||
|
2022
Q3 | $95K | Buy |
|
|||||
|
2022
Q2 | $72K | Sell |
|
|||||
|
2022
Q1 | $90K | Buy |
|
|||||
|
2021
Q4 | $168K | Sell |
|
|||||
|
2021
Q3 | $216K | Buy |
|
|||||
|
2021
Q2 | $144K | Buy |
|
|||||
|
2021
Q1 | $65K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $423K | Buy |
|
|||||
|
2020
Q1 | $105K | Buy |
|
|||||
|
2019
Q4 | $134K | Buy |
|
|||||
|
2019
Q3 | $80K | Sell |
|
|||||
|
2019
Q2 | $171K | Sell |
|
|||||
|
2019
Q1 | $166K | Sell |
|
|||||
|
2018
Q4 | $223K | Sell |
|
|||||
|
2018
Q3 | $645K | Sell |
|
|||||
|
2018
Q2 | $1.51M | Buy |
|
|||||
|
2018
Q1 | $421K | Sell |
|
|||||
|
2017
Q4 | $498K | Sell |
|
|||||
|
2017
Q3 | $798K | Sell |
|
|||||
|
2017
Q2 | $1.11M | Sell |
|
|||||
|
2017
Q1 | $1.33M | Buy |
|
|||||
|
2016
Q4 | $1M | Buy |
|
|||||
|
2016
Q3 | $1.13M | Buy |
|
|||||
|
2016
Q2 | $873K | Sell |
|
|||||
|
2016
Q1 | $1.29M | Buy |
|
|||||
|
2015
Q4 | $393K | Sell |
|
|||||
|
2015
Q3 | $322K | Sell |
|
|||||
|
2015
Q2 | $983K | Buy |
|
|||||
|
2015
Q1 | $524K | Buy |
|
|||||
|
2014
Q4 | $340K | Buy |
|
|||||
|
2014
Q3 | $187K | Sell |
|
|||||
|
2014
Q2 | $350K | Sell |
|
|||||
|
2014
Q1 | $437K | Buy |
|
|||||
|
2013
Q4 | $350K | Sell |
|
|||||
|
2013
Q3 | $741K | Buy |
|
|||||
|
2013
Q2 | $575K | Buy |
|